Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats (Q40921290)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2015
edit
Language Label Description Also known as
English
Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats
scientific article published on April 2015

    Statements

    Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit